title: Biologic agents and alopecia areata.
authors.forename: A C
authors.initials: AC
authors.lastname: Katoulis
authors.forename: A
authors.initials: A
authors.lastname: Alevizou
authors.forename: E
authors.initials: E
authors.lastname: Bozi
authors.forename: S
authors.initials: S
authors.lastname: Georgala
authors.forename: M
authors.initials: M
authors.lastname: Mistidou
authors.forename: D
authors.initials: D
authors.lastname: Kalogeromitros
authors.forename: N G
authors.initials: NG
authors.lastname: Stavrianeas
mesh_terms: D000068879:Adalimumab; D000279:Administration, Cutaneous; D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D000506:Alopecia Areata / Q000139:chemically induced* / Q000188:drug therapy / Q000523:psychology*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications*; D005260:Female; D006801:Humans; D013315:Stress, Psychological / Q000150:complications*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab